Regulatory Updates, Industry Recognition & EPiC’s GxP Compliance Symposia 2026
Our latest EPiC newsletter is now live, bringing together key regulatory developments, industry recognition, and upcoming events shaping GxP compliance in 2026.
In this edition:
- Industry Recognition: Celebrating EPiC Founder Liz Allanson’s Outstanding Contribution Award shortlisting
- EU Regulatory Update: EMA publishes the GMDP Inspectors Working Group 3‑Year Work Plan (2026–2028)
- Save the Date: EPiC’s 2026 GxP Compliance Symposia Series – three focused virtual events covering GCP, GDP and GMP
- EPiC Top Tips: Building inspection‑ready, scientifically robust stability programmes aligned with ICH Q1 and MHRA expectations
- Welcome to EPiC: Introducing Maloni Talbot, GMDP Independent Consultant specialising in aseptic services
- Conference Event Spotlight: Making Pharmaceuticals 2026 Conference – Coventry, 21–22 April (visit us at Stand 427)
From strengthening investigations and quality oversight to sharing practical compliance insight from former inspectors, this edition reflects EPiC’s continued commitment to supporting organisations across the full product lifecycle.
WHAT DO YOU REQUIRE?
WE SPECIALISE in helping pharmaceutical and biotechnology companies, as well as other associated healthcare clients, to achieve and maintain regulatory compliance and excellent pharmaceutical quality systems, to best industry standards.
If you need our help and support then please don’t hesitate to contact us.
Call: +44 (0)1244 980544
Email: enquiries@epic-auditors.com